AgeX Therapeutics, Inc. (AGE)

Financing Cash Flow

$5.20M

Quarterly · Period ending: · USD

AGE logo

AGE Financing Cash Flow

Latest reported$5.20M
AGE Quarterly Cash from Financing ($737.00K → $5.20M)
High-resolution chart · PNG

AGE financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
5,202,000
26,057,000
481,000
6,444,000
5,570,000
4,917,000
6,484,000
3,453,000
0
2,728,000
2,000,000
2,000,000
2,000,000
11,500,000
1,500,000
1,000,000
2,000,000
1,500,000
1,250,000
2,000,000
1,500,000
2,496,000
992,000
1,977,000
2,807,000
185,000
1,287,000
487,000
-9,000
4,500,000
0
263,000
5,000,000
737,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.